There are 2867 resources available
1047P - Lung-MAP S1800A: Exploratory analysis of prior immunotherapy outcomes on OS with ramucirumab plus pembrolizumab for NSCLC with PD on prior ICI
Presenter: Karen Reckamp
Session: Poster session 14
1048P - Molecular predictors of immunotherapy efficacy in lung squamous-cell carcinoma (LSCC): Results from the randomized prospective SQUINT trial
Presenter: Federico Cappuzzo
Session: Poster session 14
1150P - Progression of advanced non-small cell lung cancer after durable clinical benefit on anti-PD-1/PD-L1 monotherapy: Prolonged post-progression survival and interest of tumor growth rate
Presenter: Ivan Pourmir
Session: Poster session 16
1151P - Evolution of biomarker testing among non-squamous/non-small cell lung cancer (NSCLC) patients (Pts) and impact on turnaround times (TAT)
Presenter: Zhen (Jason) Fan
Session: Poster session 16
1152P - Lung cancer metastasis patterns and racial disparities: A SEER database population study 2010–2018
Presenter: Abdul Rahman Armashi
Session: Poster session 16
1153P - A first in class DNA repair inhibitor for the treatment of NSCLC
Presenter: Didier Boucher
Session: Poster session 16
1154P - Geriatrics predictors of 3-months overall survival and chemotherapy toxicities in older patients with metastatic non-small cell lung cancer
Presenter: Sébastien Gendarme
Session: Poster session 16
1155P - Adherence to treatment recommendations from multidisciplinary tumor boards: Initial data from 644 lung cancer cases
Presenter: Julia Roeper
Session: Poster session 16
1156P - Quality-adjusted survival with brigatinib (BRG) versus crizotinib (CRZ) in ALK-positive (ALK+) non-small cell lung cancer (NSCLC): Results from the ALTA-1L trial
Presenter: Maria Rosario Garcia Campelo
Session: Poster session 16